ArticleClinical and translational medicine2021

The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real-world multicenter study.

Xiaochen Fei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.